T

Serial Number 87978488
Registration 5588217
701

Registration Progress

Application Filed
Jul 7, 2017
Under Examination
Feb 27, 2018
Approved for Publication
Jan 2, 2018
Published for Opposition
Jan 2, 2018
Registered
Oct 16, 2018

Trademark Image

T

Basic Information

Serial Number
87978488
Registration Number
5588217
Filing Date
July 7, 2017
Registration Date
October 16, 2018
Published for Opposition
January 2, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
701
Status Date
Apr 24, 2025
Registration
Registered
Classes
042 044

Rights Holder

Tolmar International Limited

99
Address
10 Earlsfort Terrace
Dublin 2 DO2T380
IE

Ownership History

Tolmar International Limited

Original Applicant
99
Dublin 2 IE

Tolmar International Limited

Owner at Publication
99
Dublin 2 IE

Tolmar International Limited

Original Registrant
99
Dublin 2 IE

Legal Representation

Attorney
Devasena Reddy

USPTO Deadlines

Next Deadline
1191 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-10-16)
Due Date
October 16, 2028
Grace Period Ends
April 16, 2029

Application History

44 events
Date Code Type Description
Apr 24, 2025 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Apr 24, 2025 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED
Apr 22, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 30, 2024 ES8R I TEAS SECTION 8 RECEIVED
Oct 25, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 25, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 16, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 2, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 2, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 2, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 2, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 2, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 16, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 12, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 11, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 11, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 10, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Sep 10, 2018 DPCC D DIVISIONAL PROCESSING COMPLETE
Sep 10, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 13, 2018 IUAF S USE AMENDMENT FILED
Aug 13, 2018 DRRR I DIVISIONAL REQUEST RECEIVED
Aug 13, 2018 ERTD I TEAS REQUEST TO DIVIDE RECEIVED
Aug 13, 2018 EISU I TEAS STATEMENT OF USE RECEIVED
Feb 27, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 2, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 2, 2018 PUBO A PUBLISHED FOR OPPOSITION
Dec 13, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 28, 2017 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Nov 17, 2017 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 9, 2017 ALIE A ASSIGNED TO LIE
Oct 29, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 27, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 26, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2017 CPRA R PRIORITY ACTION WRITTEN
Oct 5, 2017 GPRA F PRIORITY ACTION E-MAILED
Oct 5, 2017 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 3, 2017 DOCK D ASSIGNED TO EXAMINER
Jul 15, 2017 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 14, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Scientific and technological services, namely, scientific research data analysis in the field of medicine and pharmaceuticals; scientific and technological services, namely, design and development of computer hardware and software for pharmacy inventory control and patient management of pharmaceuticals; laboratory research services relating to pharmaceuticals; industrial research in the field of topical and specialty injectable pharmaceuticals; scientific research; medical, pharmaceutical, chemical and biological research; scientific research in the field of drug discovery and development for others; biomedical research services; research and testing services in the fields of bacteriology and virology; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of oncology, topical and specialty injectable pharmaceuticals
First Use Anywhere: Mar 19, 2018
First Use in Commerce: Mar 19, 2018
Class 044
Medical services; health care; health care services in the nature of pharmaceutical consulting service and pharmaceutical and medicinal advisory services in the field of products and substances for human use; medical assistance consultancy provide by doctors and other specialized medical personnel
First Use Anywhere: Mar 19, 2018
First Use in Commerce: Mar 19, 2018

Additional Information

Design Mark
The mark consists of stylized letter "T" in a circle. The circle is divided horizontally by a band as the horizontal top portion of the letter "T". The lower half of the circle is divided by a vertical transparent band as the bottom vertical portion of the letter "T".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042 044

USPTO Documents

Loading USPTO documents...